Aizon stands at the forefront of pharmaceutical manufacturing innovation with its advanced, GMP-compliant, predictive analytics platform, distinguished by its unique combination of industrialized AI and contextualized Historian. This powerful synergy and the platform's flexibility enable Aizon to provide unparalleled insights and enhanced decision-making capabilities in Pharma Manufacturing.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/09/24 | $20,000,000 | Series C |
Atlantic Bridge Crosslink Capital NewVale Capital  Uncork Capital | undisclosed |
